Brief: Phathom Pharmaceuticals Posts Q4 Basic Shr Loss USD 1.33
28/02/2023 13:25
Feb 28 (Reuters) - Phathom Pharmaceuticals * Q4 basic EPS USD -1.33. * Q4 net income USD -55 million
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates